Community Practice

Ticagrelor is shown to be better at platelet inhibition. Warfarin seen as beneficial to patients with PAH. Dabigatran's problems aren't over.

Findings at the International AIDS Conference support the need to start antiretroviral therapy as soon as possible after diagnosis.

A round-up of OTC products to help manage dandruff and head lice.

A survey of new Rx, new generic, and new OTC products

Despite growing consumer education, children and teenagers are increasingly abusing prescription drugs. Two manufacturers have recently launched products designed to keep Rx drugs secure in the home.

The Specialty Pharmacy Certification Board has developed a Certified Specialty Pharmacist credential, which it hopes to launch in early 2013.

Medication errors can't be completely eliminated, but can CQI programs keep them to a minimum?

An encounter with a police officer reminds JP that the world sees pharmacists only as pill counters.

Federal agencies have fined an LTC provider $50 million for improperly dispensing controlled substances.

Mandatory mail-order programs are hampering medication adherence, said Marie Smith, PharmD, during a recent roundtable on medication adherence.

The ways of PBMs are convoluted and mysterious. If we don't keep a sharp eye out, one of these days we'll be getting prescriptions out of vending machines.

Readers have their say on unionization, fair reimbursement, and self-regulation.

Mepolizumab significantly reduces asthma exacerbations in patients with severe eosinophilic asthma, according to a study published in a recent issue of The Lancet.

A new technology add-on payment for Dificid (fidaxomicin) for Clostridium difficile-associated diarrhea was recently approved by the Centers for Medicare and Medicaid Services.

The new EpiPen 2-Pak holds two EpiPens plus a training pen, meant for training patients and their family members. In one hospital, however, a training pen was being stored in the emergency department’s automated dispensing cabinet.

Adults are more likely to successfully quit smoking if they take bupropion, varenicline (Chantix), or a nicotine patch, than those who attempt to quit without medication, according to the results of an ongoing prospective cohort survey published by the journal Addiction.

A fixed-dose combination of azilsartan medoxomil plus chlorthalidone (Edarbyclor, Takeda) was statistically superior to azilsartan medoxomil coadministered with hydrochlorothiazide at reducing and maintaining systolic blood pressure, according to the results of a phase 3 study published online August 31 in The American Journal of Medicine.

Tricare, the health plan for military personnel, retirees, and dependants, has decided not to put Walgreens back in its retail pharmacy network.

This year's International AIDS Conference looked toward a generation free of AIDS.

There is considerable discrepancy among caregivers and pharmacists regarding the appropriate dosage of acetaminophen for overweight and obese children, according to a recent study published online August 20 in the European Journal of Hospitality.

Early administration of intravenous aspirin, in addition to alteplase, does not improve functional outcome at 3 months for patients with acute ischemic stroke, but increases the risk of symptomatic intracranial hemorrhage, according to a study published online August 25 in The Lancet.

Anticoagulant therapy, particularly the use of aspirin, may reduce the risk of prostate cancer-specific mortality in men treated with radical prostatectomy or radiotherapy for prostate cancer, according to a study published online August 27 in the Journal of Clinical Oncology.

New anticancer agents that offer improved efficacy compared with standard therapy also increase morbidity and treatment-related mortality, according to a meta-analysis published August 20 in the Journal of Clinical Oncology.

Statins may have a protective effect against the development of colorectal cancer, according to results from a retrospective case-control study published in BMC Gastroenterology.

FDA approved enzalutamide (Xtandi, Astellas Pharma U.S. Inc. and Medivation) to treat men with late-stage (metastatic) castration-resistant prostate cancer that has spread or recurred, even with medical or surgical therapy to minimize testosterone.

The Advisory Committee on Immunization Practices recently published recommendations for the 2012-2013 influenza season.

Higher starting doses of allopurinol to treat gout may increase the risk for allopurinol hypersensitivity syndrome, according to a study published in the August 2012 issue of Arthritis & Rheumatism.

California hospitals are doing a better job of controlling methicillin-resistant Staphylococcus aureus and central-line associated bloodstream infections, according to a new report.

The National Association of Chain Drug Stores Foundation has announced the inaugural class of their Faculty Scholars Program.

Mallinckrodt, the largest U.S. supplier of opioid pain medications, plans to purchase Xanodyne Pharmaceuticals’ Roxicodone (oxycodone hydrochloride tablets USP) in 5-mg, 15-mg, and 30-mg dosage strengths.